-
公开(公告)号:US20180148783A1
公开(公告)日:2018-05-31
申请号:US15541455
申请日:2016-01-05
发明人: Andrew P. Feinberg , Andrew Ellis Jaffe , Juleen Rae Zierath , Erik Bertil Naeslund , Guang William Wong
IPC分类号: C12Q1/6883 , A61K31/7105 , A61P3/00 , A61P3/04 , A61P3/10
CPC分类号: C12Q1/6883 , A61K31/7105 , A61P3/00 , A61P3/04 , A61P3/10 , C12Q2600/118 , C12Q2600/154
摘要: The present invention provides a method for identifying a subject having or at risk of having a metabolic disease, such as diabetes or obesity. The invention is based on an approach to identify candidate genes involved in metabolic diseases, such as obesity and type 2 diabetes (T2D) through epigenetic mechanisms. The method includes identifying in the subject genetic markers correlating differentially methylated regions (DMRs) in the genome with genetic risk loci for the subject and comparing methylation patterns of the markers with a control sample from a subject not having the disease. In another embodiment, the invention also provides a method of treating a subject having or at risk of having a metabolic disease. In another embodiment, the invention provides a method of providing a prognostic evaluation of a subject having or at risk of having a metabolic disease.